Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Preparation of Poly(lactide-Co-glycolide-co-caprolactone) Nanoparticles and Their Degradation Behaviour in Aqueous Solution

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Poly(d,l-lactide-co-glycolide) Dispersions Containing Pluronics: from Particle Preparation to Temperature-Triggered Aggregation

Colloidal Characteristics of Poly(L-Lactic Acid)-b-Poly (ε-Caprolactone) Block Copolymer-Based Nanoparticles Obtained by an Emulsification/Evaporation Method

Formation and Degradation of Poly(d,l-Lactide) Nanoparticles and Their Potential Application As Controllable Releasing Devices.

In Vitro Degradation and Controlled Release Behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 Copolymer Microspheres.

Synthesis, Characterization and Application of Poly(lactic-co-glycolic acid) with a Mass Ratio of Lactic to Glycolic Segments of 52/48

Chitosan-poly(ε-caprolactone)-poly(ethylene glycol) graft copolymers: synthesis, self-assembly, and drug release behavior.

The Effect of Different Factors on Poly(lactic-co-glycolic acid) Nanoparticle Properties and Drug Release Behaviors When Co-Loaded with Hydrophilic and Hydrophobic Drugs

Polyelectrolyte Coated PLGA Nanoparticles: Templation and Release Behavior.

Preparation, Characterization, and Drug Release Behaviors of Drug-Loaded E-Caprolactone/l-lactide Copolymer Nanoparticles

Long-lasting Cross-linked PLGA-Inspired Nanoparticles from One-pot Nanopolymerization of Precisely Sequenced Short Oligolactoglycolic Acid Dimethacrylates

Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug

Preparation and Characterization of Biodegradable Nanoparticles from Methoxy Poly(ethylene Glycol)-Poly(d,l-lactide)block Copolymers As Novel Drug Carriers

Laser Light-Scattering Studies of Poly(Caprolactone-B-Ethylene Oxide-B-Caprolactone) Nanoparticles and Their Enzymatic Biodegradation

Tri-component Diblock Copolymers of Poly(ethylene Glycol)–poly(ε-Caprolactone-co-lactide): Synthesis, Characterization and Loading Camptothecin

Enzyme-catalyzed Degradation Behavior of L-Lactide/trimethylene Carbonate/glycolide Terpolymers and Their Composites with Poly(l-Lactide-co-glycolide) Fibers

Calcium Stearate as an Effective Alternative to Poly(vinyl alcohol) in Poly-Lactic-co-Glycolic Acid Nanoparticles Synthesis

PREPARATION AND CHARACTERIZATION OF BIODEGRADABLE POLYMER NANOPARTICLES